The presale process is easy, rapid, and open to all investors who want RXS at $0.20 before its listing price rises to $0.25.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback